Cytodyn Inc (CYDY)

[DonDonDonDon]

https://www.cytodyn.com/investors/sec-filings/all-sec-filings/content/0001193125-21-073448/0001193125-21-073448.pdf

Critical population:
28% (12/43) of the critically-ill population (i.e., on invasive mechanical ventilation/intubated at baseline) who received leronlimab + SoC were
discharged from the hospital within 28 days compared to only 11% (2/19) patients in the placebo + SoC group (Table4-22), a relative improvement of
approximately 166% in the proportion of patients discharged within 28 days in leronlimab group compared to SoC alone (P-value of 0.0824)

That is impressive. And it is at 28 days, not 14 days. I'm surprised that it doesn't have a p value better than .08.